Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita

scientific article published on 25 January 2016

Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1000467499
P356DOI10.1038/BMT.2015.333
P698PubMed publication ID26808569

P2093author name stringM Brown
D Myers
M Radhi
N Shreve
R Rahmetullah
P2860cites workOutcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemiaQ33392788
Telomere diseasesQ36107376
Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenitaQ36691743
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenitaQ37077955
Reduced-intensity conditioning using fludarabine and antithymocyte globulin alone allows stable engraftment in a patient with dyskeratosis congenitaQ42839610
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure.Q46177519
Dyskeratosis Congenita (DC) Registry: identification of new features of DC.Q50848237
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.Q53330217
Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimenQ56970257
Dyskeratosis congenita: Advances in the understanding of the telomerase defect and the role of stem cell transplantationQ61853258
A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenitaQ63384262
Hematopoietic stem-cell transplantation using unrelated cord-blood versus matched sibling marrow in pediatric bone marrow failure syndrome: one center's experienceQ73185895
Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenitaQ82984194
P433issue5
P921main subjectdyskeratosis congenitaQ3709312
P304page(s)744-746
P577publication date2016-01-25
P1433published inBone Marrow TransplantationQ4941523
P1476titleReduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita
P478volume51